Metagenomi Inc. (MGX) - Rasio kapitalisasi marang bathi resik

Metagenomi, Inc - logo grafis emiten MGX

The price trend reflected below, where the indicator stands at -0.30, is based on Metagenomi, Inc. (MGX) utilizing metagenomic analysis to develop innovative gene-editing tools that bypass patent restrictions. High R&D expenditures and stringent regulatory oversight create a formidable defensive barrier for the business. Despite the absence of current sales, Metagenomi, Inc. (MGX) possesses immense pricing power within the rare genetic pathology therapy segment.

MGX Metagenomi Inc.: Rasio rega marang bathi ing interval 16.08.2024 - 16.11.2026

Rincian analitis perusahaan Metagenomi, Inc.

- rega lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Metagenomi, Inc.
Produk asli Metagenomi, Inc.

The P/E ratio reflects the market value of a single unit of net profit, allowing investors to assess whether an asset is overvalued or if they are facing a value trap. By analyzing the P/E level of a company, an investor can determine the ratio of market capitalization to earnings, which for Metagenomi, Inc. (MGX), conducting leading preclinical research in the US without geopolitical risks, underscores the investment value of future technological breakthroughs in DNA editing.

Perusahaan pesaing

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Pangali P/E MGTX|Periode bali modal bisnis regenxbio.com|Pangali P/E SLDB (Solid Biosciences Inc)|OCGN: Pangali rega marang bathi|PACB - Rasio rega marang bathi|Benitec (BNTC) - Koefisien rega marang bathi|DSGN: Pangali P/E|RCKT: Rasio rega pasar marang bathi resik|FDMT (4D Molecular Therapeutics, Inc.) - Pangali P/E|lexeotx.com (LXEO) - Periode bali modal bisnis|Pangali P/E KRRO|Koefisien rega marang bathi Editas Medicine, Inc. EDIT|Rasio rega marang bathi silence-therapeutics.com SLN|PRQR: Pangali rega marang bathi|CDXS - Rasio rega marang bathi|Periode bali modal bisnis Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Koefisien rega marang bathi|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi